Updated Jul 16, 2026
LYONS GARY A has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $3.21M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1.7K | $0.00 | |
| 2026-05-21 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 8.0K | $41.07 | $329K |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 8.0K | $16.33 | $131K |
| 2025-12-04 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale [10b5-1] | 15.0K | $152.61 | $2.29M |
| 2025-12-04 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise [10b5-1] | 15.0K | $47.89 | $718K |
| 2025-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1.4K | $0.00 | |
| 2025-05-15 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 6.5K | $0.00 | |
| 2024-10-04 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale [10b5-1] | 18.8K | $15.15 | $285K |
| 2024-10-04 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale [10b5-1] | 21.2K | $14.35 | $304K |
| 2024-10-04 | TVTX | Travere Therapeutics, Inc. | M — Option exercise [10b5-1] | 40.0K | $10.48 | $419K |
LYONS GARY A is a corporate insider — currently tracked as Director of NEUROCRINE BIOSCIENCES INC (NBIX). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($3.21M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LYONS GARY A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.